• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

510(k) Premarket Notification

  • Print
  • Share
  • E-mail
-
1 to 10 of 89 Results
ProductCode: LON Applicant: BIOMERIEUX, INC. Decision Date To: 05/16/2024
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 > 
Results per Page
New Search  
Export all 89 Records to ExcelExport to Excel | Download Files | More About 510(k)
Device Name
Sort by Device Name [A-Z]
Sort by Device Name [Z-A]
Applicant
Sort by Applicant [A-Z]
Sort by Applicant [Z-A]
510(K)
Number
Sort by 510(k) Number [0-9]
Sort by 510(k) Number [9-0]
Decision
Date
Sort by Decision Date [0-9]
Sort by Decision Date [9-0]
vitek 2 ast-gram positive lefamulin (<=0.03 - >=4 µg/ml) bioMerieux, Inc. K234000 03/11/2024
vitek 2 ast-gram negative levofloxacin (/=8 ug/ml) bioMerieux, Inc. K222378 06/26/2023
vitek 2 ast-yeast caspofungin (<=0.125 - >=8 µg/ml), vitek 2 ast-ys caspofungin (<=0.125 - >=8 µg/ml), vitek 2 ast-ys caspofungin bioMerieux, Inc. K213899 07/12/2022
vitek 2 ast-gram negative omadacycline (<=0.25 - >=16 µg/ml) bioMerieux, Inc. K213931 06/03/2022
vitek 2 ast-yeast fluconazole (<=0.5->=64 µg/ml), vitek 2 ast-ys fluconazole (<=0.5->=64 µg/ml), vitek 2 ast-ys fluconazole BioMerieux, Inc. K213241 02/25/2022
vitek 2 ast-gram positive fosfomycin (<=8 - >=256 ug/ml) bioMerieux, Inc. K202396 09/14/2021
vitek 2 ast-gram negative meropenem (<= 0.25 - >=16 µg/ml) bioMerieux, Inc. K201675 07/09/2021
vitek 2 ast-gram negative ceftazidime (=<0.5 - =>32 µg/ml) BioMerieux, Inc. K193299 09/28/2020
vitek 2 ast-gram negative imipenem/relebactam (<=0.25/4 - >=16/4 µg/ml) BioMerieux, Inc. K193572 03/13/2020
vitek 2 ast- gram negative polymyxin b (<=0.25 – >=16 ug/ml) BioMerieux, Inc. K193567 02/14/2020
-
-